Abiopharma

News list

Ryan Barbara 🟢 acquired 1.3K shares of MiNK Therapeutics, Inc. (INKT) at $13.86 Transaction Date: Sep 02, 2025 | Filing ID: 195090

Full text

News bot Sept. 3, 2025, 9:30 p.m.
🔍 Ryan Barbara (Executive)

Company: MiNK Therapeutics, Inc. (INKT)

Report Date: 2025-09-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 1,281
Detailed Transactions and Holdings:
- Acquired 1,281 shares of Common Stock at $13.86 per share (Direct)
  Date: 2025-09-02 | Code: A | equity_swap_involved: false | shares_owned_after: 20,805.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.